InvestorsHub Logo
Followers 16
Posts 2841
Boards Moderated 0
Alias Born 07/24/2018

Re: None

Monday, 03/25/2019 3:48:09 PM

Monday, March 25, 2019 3:48:09 PM

Post# of 1002
Good Afternoon,

I wanted to keep you up to date with Canopy Rivers (TSX.V: RIV). The company is pleased to announce that its portfolio company, Spot Therapeutics has received a cultivation license from Health Canada for its Fredericton-based production and distribution facility. This event has triggered the repayable debenture that Canopy Rivers holds, initiating a cash flow stream for Canopy Rivers of approximately $2.85 million per year, for 25 years.

Spot Press Release: Click Here

If you would like to discuss further, please feel free to reach out.

All the best,

James Fairbanks
Investor Relations
Canopy Rivers Inc.
E: james.fairbanks@canopyrivers.com
W: canopyrivers.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RIV News